ADVERTISEMENT

COVID-19 Pandemic: Transmissions, Deaths, Treatments, Vaccines, Interventions and More...

Status
Not open for further replies.
Based on the research at Mt. Sinai showing 3+ months of stable antibody levels in ~20,000 recovered COVID patients, as well as similar work in China, showing 6 months of stable antibodies in ~350 recovered patients (both discussed in posts above), yesterday the CDC revised its quarantine guidance to say that, "People who have tested positive for COVID-19 do not need to quarantine or get tested again for up to 3 months as long as they do not develop symptoms again." This is very good news and well-justified in my opinion. My guess is these folks will be immune for at least a year.
Any news of a positive nature is good
https://www.cdc.gov/coronavirus/2019-ncov/if-you-are-sick/quarantine.html

https://www.nbcnews.com/health/heal...-covid-patients-can-t-spread-virus-3-n1236782
 
If masks were worn 100% they'd be most of the answer (although they're not 100% effective either, especially in high risk contacts), but we're far from 100%. And that video from the far right Mises Institute offered anecdotes and a mish-mash of theories on masks. Wake me up when that guy has an actual coherent data set published in a journal. Or anything published at all. I've posted numerous scientific sources showing masks work quite well, but not perfectly and some masks are better than others - would you like me to repost those for you? Plenty more to learn, but the people who are "wrong" on masks are those who say they "don't work" or that they "work 100%."


every pandemic before this one, all the journals said healthy people dont wear masks
 
every pandemic before this one, all the journals said healthy people dont wear masks
In 1918 most wore masks. In the more recent ones, which weren't true pandemics, like SARS/MERS, some wore masks in the affected countries and some didn't. And yes, the guidance was for only symptomatic people to wear masks, because both were generally contagious after symptoms appeared (with infectiousness peaking after symptoms started, which is why both were far easier to control). COVID is much different that way, with a far higher transmission rate from presymptomatic and asymptomatic people, which is why the recommendation is for healthy people to wear masks. This has been stated dozens of times - is it really that hard to understand?
 
NY State reported lowest hospitalizations since tracking. Curve crushed, time to open restaurants and gyms! 40 million people less than 500 in hospitals.
Why are you always telling lies in your posts? NYS population is 19.5 million not 40 million.
 
Just saw a report on the news about ventilation systems and how teachers should stand near them so the air droplets get sucked into it instead of it floating around the classroom. They said in an elevatpr you should try not to talk. When will the recommendation come down that we should limit talking outside so as not to spread the virus?
 

That was written on 4/1, when there was a debate going on about masks. They updated the commentary with the following about a month ago, as per below.

Editor’s Note: The authors added the following statement on Jul 16.

The authors and CIDRAP have received requests in recent weeks to remove this article from the CIDRAP website. Reasons have included: (1) we don’t truly know that cloth masks (face coverings) are not effective, since the data are so limited, (2) wearing a cloth mask or face covering is better than doing nothing, (3) the article is being used by individuals and groups to support non-mask wearing where mandated and (4) there are now many modeling studies suggesting that cloth masks or face coverings could be effective at flattening the curve and preventing many cases of infection.

These "experts" also greatly undervalued the UK study done with viruses smaller than CV, which showed 50% or more filtration efficiency from various cloth masks and ~90% from surgical masks (first link below). And to point #4, a great study with hamsters came out showing ~75% cloth mask filtration effectiveness with actual SARS-CoV-2 (and hamsters are an excellent model), as per the 2nd link. Science takes in new information and moves forward - happens all the time.

https://rutgers.forums.rivals.com/t...entions-and-more.191275/page-125#post-4571736

https://rutgers.forums.rivals.com/t...entions-and-more.191275/page-124#post-4570840
 
v0zYDsjc4ujH-Vmv8hAmy-Fsa5lCk9-Yw3-x9dUXQ_G-b6PZql7ks11XVTgPI_vgTDwUxGfPt0yV0cYPEqC0Rig65v8nztPNgZxe4tgG
 
Just saw a report on the news about ventilation systems and how teachers should stand near them so the air droplets get sucked into it instead of it floating around the classroom. They said in an elevatpr you should try not to talk. When will the recommendation come down that we should limit talking outside so as not to spread the virus?

FNfXF2t.jpg
 
So a discussion in another thread about the Rutgers saliva test. Last I read they were at about 10k tests a day and still limited to in system members only. Has that changed dramatically? Hope so.
 
Huge COVID party going on in New Providence.
Streets lined with out of state cars.
Can hear the DJ from around the block.

Abandoned/foreclosed AirBnB that has been vacant for a while.

Wonder if we will make nj.com tomorrow.

NJ - another "backwards state" I guess......
 
Given some of the talk about Merck etc., and after reading in Barron's that Merck was its stock pick of the week, I wanted to check on Merck’s stock performance. Somewhat arbitrarily I picked the last 5 years as my comparator against two other Big Pharma companies, Novartis and Pfizer. And discovered that the timing of the most recent post about Merck was, to put it mildly, a bit off.

First of all, a straightforward Yahoo Finance 5 year finance comparator chart showed that Merck was up 49.69% versus 13.48% for Pfizer and MINUS 1.36% for Novartis. And the market rewards expectations of FUTURE earnings, not past performance. So much for Merck being a "shell of itself", etc.

BTW, I was glad to see that negative number for Novartis because I had been upset about their corporate behavior. Just on July 1, 2020, NVS paid all of us taxpayers over $642 Million to settle allegations of improper payments to patients and physicians. And separately, $51 Million to resolve allegations that it paid kickbacks through something they created called “co-pay foundations”. Perhaps the "weird culture" is elsewhere?
 
Given some of the talk about Merck etc., and after reading in Barron's that Merck was its stock pick of the week, I wanted to check on Merck’s stock performance. Somewhat arbitrarily I picked the last 5 years as my comparator against two other Big Pharma companies, Novartis and Pfizer. And discovered that the timing of the most recent post about Merck was, to put it mildly, a bit off.

First of all, a straightforward Yahoo Finance 5 year finance comparator chart showed that Merck was up 49.69% versus 13.48% for Pfizer and MINUS 1.36% for Novartis. And the market rewards expectations of FUTURE earnings, not past performance. So much for Merck being a "shell of itself", etc.

BTW, I was glad to see that negative number for Novartis because I had been upset about their corporate behavior. Just on July 1, 2020, NVS paid all of us taxpayers over $642 Million to settle allegations of improper payments to patients and physicians. And separately, $51 Million to resolve allegations that it paid kickbacks through something they created called “co-pay foundations”. Perhaps the "weird culture" is elsewhere?
Thanks for posting Numbers. You really don't need the second username. Your logic and facts are still faulty, but nice try!

Pharma is about innovation and invention. Fortune tracks this every year, here are the top 5 companies to watch:

Roche
Innovation Index rank: 1
Invention Index rank: 10

Number of employees: 97,735
2019 revenue: $63.638 billion
Headquarters: Basel, Switzerland

Roche has jumped seven spots from 2019 to finish first, the first time the Swiss company has done so. The company benefited from multiple clinical data wins, a pair of novel FDA approvals, and many path-leading immuno-oncology firsts by its PD-L1, Tecentriq.

AbbVie
Innovation Index rank: 2
Invention Index rank: 7

Number of employees: 30,000
2019 revenue: $32.75 billion
Headquarters: North Chicago, Ill., U.S.

Runner-up on this year’s Innovation Index (and seventh overall on the Invention ranking) is AbbVie. A model of consistency, AbbVie has held the second position two years in a row.

Novartis
Innovation Index rank: 3
Invention Index rank: 4

Number of employees: 103,914
2019 revenue: $51.9 billion
Headquarters: Basel, Switzerland

Novartis had a historic year in terms of regulatory approvals notching an unprecedented five novel drugs, helping catapult the company from ninth on the Innovation Index in 2019 to third in 2020. Notably, the company also sustained its Invention ranking—finishing fourth overall in back-to-back years, suggesting a promising future.

Vertex
Innovation Index rank: 3
Invention Index rank: 9

Number of employees: 3,000
2019 revenue: $4.164 billion
Headquarters: Boston, Mass., U.S.

With the help of the FDA approval of potential blockbuster cystic fibrosis (CF) drug Trikafta, Vertex burst onto the Innovation scale in 2019, as the best-performing biotech by far.

Eli Lilly
Innovation Index rank: 5
Invention Index rank: 3

Number of employees: 33,625
2019 revenue: $22.32 billion
Headquarters: Indianapolis, Ind., U.S.

After experiencing a jump from No. 13 in 2018 to third on the 2019 Innovation scale, Eli Lilly has settled into the fifth spot on this year’s Index. Despite the two-spot drop, Lilly’s Invention scale ranking of third for 2020 implies that the company isn’t going anywhere anytime soon.

https://fortune.com/2020/04/06/top-pharmaceutical-companies-innovation-invention-2020/
 
Last edited:
Huge COVID party going on in New Providence.
Streets lined with out of state cars.
Can hear the DJ from around the block.

Abandoned/foreclosed AirBnB that has been vacant for a while.

Wonder if we will make nj.com tomorrow.

NJ - another "backwards state" I guess......
State allows up to 500 outside. Have a beer and relax.
 
I don't think Merck retired @RU848789 , but as per his own words, Merck demoted him.

And remember, Merck is a shell of its former self. It's the PSU of the pharma industry. They caused the biggest cover-up/scandal in history and have a very weird culture. They also pay on the low end of base salary and bonus structure.

Yeah, like I ever said that. Keep trolling. It's also not really appropriate to talk about other people's jobs/personal lives, especially if you're going to lie. I could say all kinds of things about your career, but that would be wrong, too, so I won't. But if you don't think your employer might be watching you on line, think again, and you might want to consider how your trolling/lying posting style and questionable content would look to HR. Just some free advice.
 
Pretty cool paper from Scripps, using supercold electron microscopy to elucidate the structure of the genetically engineered Novavax spike protein structure in its vaccine, which mimics the structure of the spike protein in the actual coronavirus, so that it will stimulate the body to produce antibody responses (these antibody responses have been seen in the early clinical trials so far) to bind to and deactivate the virus. I learned a decent amount about electron microscopy (of crystals - from a crystallographer at work) early in my career and its simply an amazing analytical tool for structure analysis and its capabilities have grown hugely in the last 20 years. Some neat visuals in the actual paper (2nd link).

https://www.scripps.edu/news-and-events/press-room/2020/20200807-ward-covidvaccine.html

https://www.biorxiv.org/content/10.1101/2020.08.06.234674v1.full.pdf
 
Thanks for posting Numbers. You really don't need the second username. Your logic and facts are still faulty, but nice try!

Pharma is about innovation and invention. Fortune tracks this every year, here are the top 5 companies to watch:

Roche
Innovation Index rank: 1
Invention Index rank: 10

Number of employees: 97,735
2019 revenue: $63.638 billion
Headquarters: Basel, Switzerland

Roche has jumped seven spots from 2019 to finish first, the first time the Swiss company has done so. The company benefited from multiple clinical data wins, a pair of novel FDA approvals, and many path-leading immuno-oncology firsts by its PD-L1, Tecentriq.

AbbVie
Innovation Index rank: 2
Invention Index rank: 7

Number of employees: 30,000
2019 revenue: $32.75 billion
Headquarters: North Chicago, Ill., U.S.

Runner-up on this year’s Innovation Index (and seventh overall on the Invention ranking) is AbbVie. A model of consistency, AbbVie has held the second position two years in a row.

Novartis
Innovation Index rank: 3
Invention Index rank: 4

Number of employees: 103,914
2019 revenue: $51.9 billion
Headquarters: Basel, Switzerland

Novartis had a historic year in terms of regulatory approvals notching an unprecedented five novel drugs, helping catapult the company from ninth on the Innovation Index in 2019 to third in 2020. Notably, the company also sustained its Invention ranking—finishing fourth overall in back-to-back years, suggesting a promising future.

Vertex
Innovation Index rank: 3
Invention Index rank: 9

Number of employees: 3,000
2019 revenue: $4.164 billion
Headquarters: Boston, Mass., U.S.

With the help of the FDA approval of potential blockbuster cystic fibrosis (CF) drug Trikafta, Vertex burst onto the Innovation scale in 2019, as the best-performing biotech by far.

Eli Lilly
Innovation Index rank: 5
Invention Index rank: 3

Number of employees: 33,625
2019 revenue: $22.32 billion
Headquarters: Indianapolis, Ind., U.S.

After experiencing a jump from No. 13 in 2018 to third on the 2019 Innovation scale, Eli Lilly has settled into the fifth spot on this year’s Index. Despite the two-spot drop, Lilly’s Invention scale ranking of third for 2020 implies that the company isn’t going anywhere anytime soon.

https://fortune.com/2020/04/06/top-pharmaceutical-companies-innovation-invention-2020/
Is there a point here? If you rank the companies in any segment of the economy, somebody has to be first, second, etc. Says nothing about whether they are innovative compared to other companies.
 
  • Like
Reactions: Greg2020 and LC-88
Pretty cool paper from Scripps, using supercold electron microscopy to elucidate the structure of the genetically engineered Novavax spike protein structure in its vaccine, which mimics the structure of the spike protein in the actual coronavirus, so that it will stimulate the body to produce antibody responses (these antibody responses have been seen in the early clinical trials so far) to bind to and deactivate the virus. I learned a decent amount about electron microscopy (of crystals - from a crystallographer at work) early in my career and its simply an amazing analytical tool for structure analysis and its capabilities have grown hugely in the last 20 years. Some neat visuals in the actual paper (2nd link).

https://www.scripps.edu/news-and-events/press-room/2020/20200807-ward-covidvaccine.html

https://www.biorxiv.org/content/10.1101/2020.08.06.234674v1.full.pdf
In spite of all the nonsense you've had to put up with, I, and I'm guessing lots of other readers, truly appreciate your insight, dedication, and presentation of information in this thread. Good on ya, mate!
 
For a few months now, the EU has had far, far less cases and deaths than the US - that's why the comparisons have looked bad for the US. However, over the past couple of weeks, cases are surging in many parts of Europe, including the countries you mentioned, although they're still only about 10% of the US's cases, per capita (and deaths are <5% per capita, but they lag cases).

If they end up going through what we did, where areas not very hard hit in the first wave get hit hard in the 2nd wave, they'll look just as foolish as we have for letting that happen. Jury is still out on that happening though, as those countries are responding aggressively. August is when everyone takes their holidays in Europe, so it's not a surprise that cases are going up. Jury is also out in Hawaii - they're nowhere near the levels per capita of other states and they're responding aggressively. None of this is easy (other than wearing masks).

https://www.bbc.com/news/world-europe-53747852

You probably know that I am not on a particular "side" in this, as taking sides is foolish--but I take issue with "look just as foolish as we have for letting that happen." Really? Foolish? People worldwide are tired of lockdowns and the economic damage it has and continues to cause. It received very little press, and the mainstream news would not publish the actual numbers, but there was a rally to end the lockdown in Germany in the last few weeks that drew close to 1,000,000 protesters.

It is a fair question and subject to debate how much longer we extend lockdowns. The article I posted above from Australia makes some fair points.
 
  • Like
Reactions: Wolv RU
Huge COVID party going on in New Providence.
Streets lined with out of state cars.
Can hear the DJ from around the block.

Abandoned/foreclosed AirBnB that has been vacant for a while.

Wonder if we will make nj.com tomorrow.

NJ - another "backwards state" I guess......

Where was this?
 
Yeah, like I ever said that. Keep trolling. It's also not really appropriate to talk about other people's jobs/personal lives, especially if you're going to lie. I could say all kinds of things about your career, but that would be wrong, too, so I won't. But if you don't think your employer might be watching you on line, think again, and you might want to consider how your trolling/lying posting style and questionable content would look to HR. Just some free advice.


I'm always looking at Bac's posts and call him in the office weekly to scold him on his post. He says the same for me,
 
Is there a point here? If you rank the companies in any segment of the economy, somebody has to be first, second, etc. Says nothing about whether they are innovative compared to other companies.
Pretty simple point. We were talking about pharma companies and I posted an article about pharma companies. Don't understand your question here.
 
Yeah, like I ever said that. Keep trolling. It's also not really appropriate to talk about other people's jobs/personal lives, especially if you're going to lie. I could say all kinds of things about your career, but that would be wrong, too, so I won't. But if you don't think your employer might be watching you on line, think again, and you might want to consider how your trolling/lying posting style and questionable content would look to HR. Just some free advice.
You are correct

He went far over any line of decency
 
Quite a harsh rebuke of Australia's lockdown:
https://www.theaustralian.com.au/in...y/news-story/b403b6fa3b30879654a80d8e5c7aa6f0

"The ultimate showcase of political innumeracy is the quasi-religious ritual of The Reading of the Cases. ...
Until we are entrusted with the knowledge of how many are the results of tests on people who show no symptoms, they serve only to strike terror into the innumerate."

"Their primary purpose seems to be to post-rationalise our leaders’ devastating, simple-minded lockdowns and border closures, and to panic people into sporting their masks of obedience should they be sufficiently reckless as to leave their homes."

"How could anyone who had wreaked damage on this cataclysmic scale ever admit to themselves, let alone to the nation, that it was all for nothing? Instead, like the pokie addict, they have doubled down to unleash a runaway epidemic of stupidity. They’ve destroyed our economy and put thousands out of work; they’ve refashioned many of our famously easygoing population into masked informers; and we’ve handed control of our lives to a clown car packed with idiots."

"Governments don’t exist to tell us how or when we can die; but if life is measured only by length, not quality, this is where we end up: imprisoned, supposedly for our own good, on the basis of flawed statistical modelling and even worse interpretations of that modelling."

"Cases, as a moment’s reflection reveals, do not equal sickness, much less hospitalisations."

We've been down this road very recently in the US. And this was the exact argument, but as it turned out, and not unexpectedly, hospitalization #'s will rise in the wake of rising case #'s and deaths will follow along after that.

I understand people are tired of the shut down, and even more importantly the shut downs crippling of the economy, but would it be a better idea to be ahead of the curve or to wait until you get to the point where your hospitals are being overrun and the deaths are piling up?
 
  • Like
Reactions: Greg2020
Status
Not open for further replies.
ADVERTISEMENT
ADVERTISEMENT